GP1BA and autoimmune thrombocytopenic purpura: We then tested the therapeutic potential of oseltamivir phosphate (Tamiflu), a commonly administered anti-influenza medication that inhibits viral neuraminidase, and found significant amelioration of platelet counts in our murine model of anti-GPIbα-mediated ITP (Fig. 8d).